News

Indian researchers produced the first combined molecular and functional profile of the venom gland of the colonial spider Stegodyphus sarasinorum. The study found molecules that may guide future drug discovery. It does not establish a cancer treatment.

Updates

  • Integrated molecular map: The study combined transcriptomics, proteomics, metabolomics and Confocal Raman spectroscopy to examine the venom gland.
  • Protein components: Transcriptomic analysis identified 31 annotated protein components. Proteomic analysis identified 32 proteins.
  • Small molecules: Ultra-high-performance liquid chromatography–mass spectrometry identified 81 metabolites, including amino acids, nucleotides and organic acids.
  • Laboratory activity: Venom-gland extracts showed dose-dependent cytotoxicity against Dalton’s lymphoma ascites cancer cells. They also showed antioxidant activity in laboratory assays.
  • Research limit: The result comes from cell and biochemical tests. Researchers must isolate the active molecules and test safety in healthy cells, animals and clinical trials.

About Colonial Spider

  • Species: Stegodyphus sarasinorum, also called the Indian cooperative spider, is a permanent social spider of the family Eresidae.
  • Shared colony: Many spiders live in one silk nest and maintain a surrounding capture web. This differs from the solitary life of most spiders.
  • Cooperative hunting: Colony members respond to web vibrations, capture prey together and share feeding.
  • South Asian range: The species occurs in India, Sri Lanka, Nepal and Myanmar. It is associated with dry and semi-arid vegetation that can support its large silk nests.

About Multi-omics Profiling

  • Combined evidence: Multi-omics studies RNA, proteins and small molecules together. It gives a broader molecular picture than one test.
  • Candidate selection: It helps researchers identify particular venom molecules for isolation and testing.
  • Early stage: A drug lead is only a starting point. It must pass safety, animal and human testing before it can become a medicine.

Why the Finding Matters

  • Targeted drug discovery: The molecular map can help researchers test individual venom molecules instead of relying on a crude venom extract.
  • Natural-product research: Spider venoms contain bioactive peptides and other molecules that may offer templates for antimicrobial, antioxidant or anti-cancer research.
  • Evidence-based caution: Activity against laboratory cancer cells cannot predict benefit or safety in patients.

Source: Scientific Reports